Comparison of Deep Versus Awake Tracheal Extubation in Adults (CDATE)

May 3, 2023 updated by: Michael Andrew Lee, United States Navy
Prospective, randomized, single-blinded controlled study to compare the airway and respiratory complications of deep and awake tracheal extubations in adults.

Study Overview

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Portsmouth, Virginia, United States, 23708
        • Naval Medical Center Portsmouth

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ASA physical status classification system for assessing the fitness of patients before surgery 1-3
  • Meeting American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting
  • Adult patients age 18-64
  • Favorable airway examinations (Mallampati 1 or 2, normal mouth opening, and intact neck extension)
  • Scheduled cases in which tracheal intubation and general anesthesia are indicated

Exclusion Criteria:

  • Patients with chronic obstructive pulmonary disease, pulmonary hypertension, interstitial lung disease, active respiratory infections, and/or uncontrolled asthma
  • Unfavorable airway examinations (Mallampati 3 or 4, limited mouth opening, and/or inability to extend neck)
  • Full stomach
  • Known difficult intubation or mask ventilation
  • Surgeries of the airway and intrathoracic surgeries
  • Emergent surgeries
  • Case duration >6 hours
  • Pregnancy
  • Patients scheduled to receive a protocolized anesthetic (Enhanced Recovery After Surgery aka ERAS)
  • ASA Physical Status Classification 4 or 5
  • Chronic diseases such as obstructive pulmonary disease, pulmonary hypertension, interstitial lung disease, active respiratory infections, and/or uncontrolled asthma
  • Uncontrolled gastroesophageal reflux disease (heartburn) defined by presence of symptoms despite compliance with appropriate medication regimen
  • Patient scheduled to receive a protocolized anesthetic ie Enhanced Recovery After Anesthesia (ERAS)
  • Surgeries requiring prone positioning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Awake Extubation
Removal of the endotracheal tube while the patient is no longer under general anesthesia
Removal of the endotracheal tube
Active Comparator: Deep Extubation
Removal of the endotracheal tube while the patient is under general anesthesia
Removal of the endotracheal tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aggregate Rate of Airway and Respiratory Complications
Time Frame: Peri-extubation period
Coughing, obstruction, apnea, hypoxemia, bronchospasm, laryngospasm, aspiration
Peri-extubation period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence and Severity of Postoperative Sore Throat
Time Frame: At time of transfer from PACU Phase 1 to PACU Phase 2 once PACU Phase 1 discharge criteria met, minimum of twenty minutes
Sore Throat Rated on 0-10 Visual Analog Scale
At time of transfer from PACU Phase 1 to PACU Phase 2 once PACU Phase 1 discharge criteria met, minimum of twenty minutes
Peri-extubation Heart Rate
Time Frame: Peri-extubation period
Beats per minute, Incidence and Severity of Tachycardia (defined as 20% from Baseline Heart Rate)
Peri-extubation period
Peri-extubation Blood Pressure
Time Frame: Peri-extubation period
Systolic, Diastolic, and Mean Arterial Pressure in Millimeters of Mercury by Non-Invasive Blood Pressure, Incidence and Severity of Hypertension and Hypotension (defined as 20% from Baseline Blood Pressure)
Peri-extubation period
End-of-Surgery to Out-Of-Room Time
Time Frame: From End-of-Surgery Time (defined by surgical dressing application) to Out-of-Room Time (defined by patient physically leaving operating room), up to two hours
Duration in Minutes
From End-of-Surgery Time (defined by surgical dressing application) to Out-of-Room Time (defined by patient physically leaving operating room), up to two hours
Peri-extubation Agitation
Time Frame: From ten minutes prior to extubation to transfer time from PACU Phase 1 to PACU Phase 2 (minimum PACU Phase 1 stay 20 minutes)
Incidence of Richmond Agitation-Sedation Scale score >=2
From ten minutes prior to extubation to transfer time from PACU Phase 1 to PACU Phase 2 (minimum PACU Phase 1 stay 20 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2020

Primary Completion (Actual)

April 26, 2023

Study Completion (Actual)

April 26, 2023

Study Registration Dates

First Submitted

April 23, 2022

First Submitted That Met QC Criteria

April 30, 2022

First Posted (Actual)

May 5, 2022

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

May 3, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • NMCP.2020.0097

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Complication of Anesthesia

Clinical Trials on Extubation

3
Subscribe